| Financial Year |
March 31 2023 |
| Monetary Funds |
510,708,292.17 |
| Held-for-trading Financial Assets |
20,219,513.89 |
| Notes Receivable |
4,088,000.00 |
| Accounts Receivable |
202,807,517.25 |
| Advances to Suppliers |
12,034,899.69 |
| Other Receivables |
15,682,625.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
70,352,716.27 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,424,834.06 |
| Total Current Assets |
1,176,582,807.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
13,354,764.68 |
| Long-term Equity Investment |
-- |
| Investment Properties |
58,087,245.87 |
| Fixed Assetes |
74,324,583.78 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
36,473,819.73 |
| R&D expenses |
36,180,574.07 |
| Goodwill |
926,638.80 |
| Long-Term Deferred and Prepaid Expenses |
22,188,884.38 |
| Deferred Income Tax Assets |
24,961,068.15 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
269,232,022.60 |
| Total Assets |
1,445,814,829.99 |
| Short-Term Loans |
151,123,587.50 |
| Trading Financial liabilities |
-- |
| Notes Payable |
12,800,905.12 |
| Accounts Payable |
184,139,882.05 |
| Accounts Received In Advance |
947,764.47 |
| Employee Compensation Payable |
29,606,005.84 |
| Taxes Payable |
1,364,905.40 |
| Interest Payable |
-- |
| Dividend Payable |
17,906.20 |
| Other payables |
5,755,617.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,378,253.03 |
| Other Current Liabilities |
1,240,103.66 |
| Sub-Total of Current Liabilities |
401,102,090.82 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
825,929.32 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,122,853.25 |
| Total Liabilities |
403,224,944.07 |
| Paid-In Capital(Or Share Stock) |
262,738,501.00 |
| Capital Surplus |
612,222,471.03 |
| Surplus Reserve |
30,046,835.47 |
| LESS:Treasury Stock |
1,553,793.80 |
| Undistributed Profits |
137,657,027.36 |
| Minority Stockholder's Interest |
1,478,844.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,041,111,041.06 |
| Owner's Equity（Stockholder's Equity） |
1,042,589,885.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,445,814,829.99 |
